Enho Mutations Causing Low Adropin: A Possible Pathomechanism of MPO-ANCA Associated Lung Injury

EBioMedicine

Jun Fang¹  Chengdang Wang²  Qicai Liu³  Sheng Zhang⁴  Feng Gao⁴  Shaohuang Weng⁵  Xin-hua Lin⁵  Shu Chen⁵  Xiaoting Lv⁶  Jinchi Zhang⁷  Qingliang He⁷  Falin Chen⁸ 

[1] Department of Cardiology, Affiliated Union Hospital, Fujian Medical University, Fuzhou, Fujian, China;Department of Gastroenterology, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China;Department of Laboratory Medicine, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China;Department of Pathology, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China;Department of Pharmaceutical Analysis, Fujian Medical University, Fuzhou, Fujian, China;Department of Respiratory, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China;Department of Surgery, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China;Fujian Provincial Center for Clinical Laboratory, Fujian Provincial Hospital, Fuzhou, Fujian, China;

关键词: Enho mutations;    Adropin;    MPO-ANCA associated lung injury;    eNOS;   

DOI  :  10.1016/j.ebiom.2016.05.036

来源: DOAJ

【 授权许可】

Unknown